Pain Perception: Mediates dynorphin-induced analgesia by reducing neurotransmitter release in spinal cord pathways .
Neurotransmitter Regulation: Inhibits presynaptic calcium currents and enhances potassium conductance, dampening nociceptive signaling .
Addiction Pathways: Genetic variations correlate with alcohol dependence and opioid addiction susceptibility .
Single-cell RT-PCR studies in rodents revealed:
Primary Afferents: Oprk1 is expressed in 50–60% of colon- and bladder-innervating afferents but only 7% of muscle afferents .
Peptidergic Neurons: Co-expressed with calcitonin gene-related peptide (CGRP), substance P (Tac1), and TRPV1, marking a subset involved in inflammatory pain .
Oprk1-positive peptidergic neurons show elevated expression of:
Tac1 (substance P)
Trpv1 (heat/capsaicin receptor)
Gfrα3 (GDNF receptor)
This suggests specialized roles in nociception and neuroimmune interactions .
Ligand Binding: Used to screen KOR agonists/antagonists (e.g., U69593) via radiolabeled diprenorphine displacement .
cAMP Inhibition: Quantifies receptor activity by measuring forskolin-induced cAMP reduction .
Polyclonal antibodies (e.g., Bioss bs-1094R) target epitopes in the C-terminal domain for immunohistochemistry and Western blotting .